Not Yet Recruiting
Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC
NCT06768255
- Conditions
- Abiraterone Acetate, mCRPC (Metastatic Castration-resistant Prostate Cancer)
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Pudong New Area, China